Rating History for Karyopharm Therapeutics (KPTI) by Leerink Partners
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/6/2021 | Jonathan Chang | Downgrade | Market Perform (Outperform) |
6.00 (N/A) |
7.82 (1.09) |
-86.06% | Details |
 |
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
